These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 27693798

  • 1. Chronic LPSF/GQ-02 treatment attenuates inflammation and atherosclerosis development in LDLr-/- mice.
    Silva AKSE, Gomes FODS, Santos Silva BD, Ribeiro EL, Oliveira AC, Araújo SMDR, de Lima IT, Oliveira AGV, Rudnicki M, Abdalla DSP, Lima MDCA, Pitta IDR, Peixoto CA.
    Eur J Pharmacol; 2016 Nov 15; 791():622-631. PubMed ID: 27693798
    [Abstract] [Full Text] [Related]

  • 2. Effect of new thiazolidine derivatives LPSF/GQ-02 and LPSF/GQ-16 on atherosclerotic lesions in LDL receptor-deficient mice (LDLR(-/-)).
    Soares E Silva AK, de Oliveira Cipriano Torres D, Santos Rocha SW, dos Santos Gomes FO, dos Santos Silva B, Donato MA, Raposo C, Santos AC, de Lima Mdo C, Galdino SL, da Rocha Pitta I, de Souza JR, Peixoto CA.
    Cardiovasc Pathol; 2013 Nov 15; 22(1):81-90. PubMed ID: 22795892
    [Abstract] [Full Text] [Related]

  • 3. LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD).
    Soares e Silva AK, de Oliveira Cipriano Torres D, dos Santos Gomes FO, dos Santos Silva B, Lima Ribeiro E, Costa Oliveira A, dos Santos LA, de Lima Mdo C, Pitta Ida R, Peixoto CA.
    PLoS One; 2015 Nov 15; 10(4):e0123787. PubMed ID: 25875942
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New thiazolidinedione LPSF/GQ-2 inhibits NFκB and MAPK activation in LPS-induced acute lung inflammation.
    Santos LAMD, Rodrigues GB, Mota FVB, França MER, de Souza Barbosa KP, Oliveira WH, Rocha SWS, Lós DB, Silva AKS, Silva TGD, Peixoto CA.
    Int Immunopharmacol; 2018 Apr 15; 57():91-101. PubMed ID: 29475100
    [Abstract] [Full Text] [Related]

  • 7. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR, Ishiguro H, Ding L, Yancey PG, Dove DE, Kovacs WJ, Semenkovich CF, Fazio S, Linton MF.
    Circulation; 2007 Sep 18; 116(12):1404-12. PubMed ID: 17724261
    [Abstract] [Full Text] [Related]

  • 8. New indole-thiazolidine attenuates atherosclerosis in LDLr(-/-) mice.
    César FA, Rudnicki M, de Las Heras B, Boscá L, Lima MC, Pitta IR, Abdalla DS.
    Vascul Pharmacol; 2015 Aug 18; 71():174-80. PubMed ID: 25869519
    [Abstract] [Full Text] [Related]

  • 9. PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients.
    de Almeida AR, Dantas AT, de Oliveira Gonçalves ME, Chêne C, Jeljeli M, Chouzenoux S, Thomas M, Cunha EGC, de Azevedo Valadares LD, de Melo Gomes JV, de Paula SKS, da Rocha Pitta MG, da Rocha Pitta I, de Melo Rêgo MJB, Pereira MC, Duarte ALBP, Abdalla DSP, Nicco C, Batteux F, da Rocha Pitta MG.
    Inflammopharmacology; 2024 Feb 18; 32(1):433-446. PubMed ID: 37477795
    [Abstract] [Full Text] [Related]

  • 10. Anti-atherogenic effect of BHB-TZD having inhibitory activities on cyclooxygenase and 5-lipoxygenase in hyperlipidemic mice.
    Choi JH, Jeon HJ, Park JG, Sonn SK, Lee MR, Lee MN, You HJ, Kim GY, Kim JH, Lee MH, Kwon OS, Nam KH, Kim HC, Jeong TS, Lee WS, Oh GT.
    Atherosclerosis; 2010 Sep 18; 212(1):146-52. PubMed ID: 20684827
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the action of LPSF/GQ-16 on cytokines and PPAR-γ gene expression after in vitro irradiation of peripheral blood mononuclear cells.
    Brayner Cavalcanti M, Bezerra Leite LL, Manoel de Queiroz D, de Salazar E Fernandes T, Mendes de Oliveira WL, Pereira MC, da Rocha Pitta MG, de Melo Rêgo MJB, Dos Santos Júnior JA, Herrero Fernández Z, Rodrigues Cravo Teixeira D, Galdino da Rocha Pitta M, da Rocha Pitta I, César Dantas S, Cavalcante Veras R, Almeida de Medeiros I, Borges da Silva E.
    Int J Radiat Biol; 2021 Sep 18; 97(12):1649-1656. PubMed ID: 34586957
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
    Bojic LA, Burke AC, Chhoker SS, Telford DE, Sutherland BG, Edwards JY, Sawyez CG, Tirona RG, Yin H, Pickering JG, Huff MW.
    Arterioscler Thromb Vasc Biol; 2014 Jan 18; 34(1):52-60. PubMed ID: 24158519
    [Abstract] [Full Text] [Related]

  • 13. Anti-atherosclerotic and anti-inflammatory actions of sesame oil.
    Narasimhulu CA, Selvarajan K, Litvinov D, Parthasarathy S.
    J Med Food; 2015 Jan 18; 18(1):11-20. PubMed ID: 25562618
    [Abstract] [Full Text] [Related]

  • 14. Metabonomic Changes Associated with Atherosclerosis Progression for LDLR(-/-) Mice.
    Li D, Zhang L, Dong F, Liu Y, Li N, Li H, Lei H, Hao F, Wang Y, Zhu Y, Tang H.
    J Proteome Res; 2015 May 01; 14(5):2237-54. PubMed ID: 25784267
    [Abstract] [Full Text] [Related]

  • 15. GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr-/- mice.
    Silva JC, de Oliveira EM, Turato WM, Trossini GHG, Maltarollo VG, Pitta MGR, Pitta IR, de Las Heras B, Boscá L, Rudnicki M, Abdalla DSP.
    Int J Obes (Lond); 2018 Jun 01; 42(5):1062-1072. PubMed ID: 29453462
    [Abstract] [Full Text] [Related]

  • 16. Water-Soluble Components of Sesame Oil Reduce Inflammation and Atherosclerosis.
    Narasimhulu CA, Selvarajan K, Burge KY, Litvinov D, Sengupta B, Parthasarathy S.
    J Med Food; 2016 Jul 01; 19(7):629-37. PubMed ID: 27348418
    [Abstract] [Full Text] [Related]

  • 17. Anti-atherosclerotic effect of hesperidin in LDLr-/- mice and its possible mechanism.
    Sun YZ, Chen JF, Shen LM, Zhou J, Wang CF.
    Eur J Pharmacol; 2017 Nov 15; 815():109-117. PubMed ID: 28899694
    [Abstract] [Full Text] [Related]

  • 18. Anti-atherosclerotic potential of baicalin mediated by promoting cholesterol efflux from macrophages via the PPARγ-LXRα-ABCA1/ABCG1 pathway.
    He XW, Yu D, Li WL, Zheng Z, Lv CL, Li C, Liu P, Xu CQ, Hu XF, Jin XP.
    Biomed Pharmacother; 2016 Oct 15; 83():257-264. PubMed ID: 27389392
    [Abstract] [Full Text] [Related]

  • 19. Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone.
    Nakaya H, Summers BD, Nicholson AC, Gotto AM, Hajjar DP, Han J.
    Am J Pathol; 2009 Jun 15; 174(6):2007-14. PubMed ID: 19435790
    [Abstract] [Full Text] [Related]

  • 20. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet.
    Hu C, Dandapat A, Sun L, Chen J, Marwali MR, Romeo F, Sawamura T, Mehta JL.
    Cardiovasc Res; 2008 Jul 15; 79(2):287-93. PubMed ID: 18453637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.